Matrix metalloproteinases at cancer tumor-host interface.

The increasing diversity in both substrates and functions of matrix metalloproteinases (MMPs) makes these enzymes central regulators in the complex tumor ecosystem composed of cancer cells and their microenvironment. In the majority of cancers, membrane-associated and extracellular proteases are mainly produced by host cells including inflammatory cells, endothelial cells, pericytes and fibroblasts. Recent data based on in vitro and in vivo studies have demonstrated the relevance of these enzymes in multiple processes controlling cancer growth, angiogenesis and metastatic dissemination. This review will present the emerging MMP-related features of cancer cells and host cells.

[1]  M. Rio.  From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation. , 2005, Biochimie.

[2]  S. Weiss,et al.  Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.

[3]  C. López-Otín,et al.  Loss of collagenase-2 confers increased skin tumor susceptibility to male mice , 2003, Nature Genetics.

[4]  D. Pinkel,et al.  The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.

[5]  A. M. Houghton,et al.  Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. , 2006, Cancer research.

[6]  I. Fidler,et al.  Macrophage-Derived Metalloelastase Is Responsible for the Generation of Angiostatin in Lewis Lung Carcinoma , 1997, Cell.

[7]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[8]  J. Ward,et al.  MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover , 1999, Cell.

[9]  B. Sheu,et al.  A novel role of metalloproteinase in cancer-mediated immunosuppression. , 2001, Cancer research.

[10]  C. Libert,et al.  Matrix metalloproteinase-8: cleavage can be decisive. , 2006, Cytokine & growth factor reviews.

[11]  U. Felbor,et al.  Generation and degradation of human endostatin proteins by various proteinases , 2000, FEBS letters.

[12]  Christopher M Overall,et al.  Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. , 2006, Nature reviews. Cancer.

[13]  X. Puente,et al.  LPS Responsiveness and Neutrophil Chemotaxis In Vivo Require PMN MMP-8 Activity , 2007, PloS one.

[14]  D. Edwards,et al.  Metalloproteinases and their inhibitors in tumor angiogenesis , 2005, International journal of cancer.

[15]  C. Overall,et al.  Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* , 2001, The Journal of Biological Chemistry.

[16]  W. Parks,et al.  Epilysin, a Novel Human Matrix Metalloproteinase (MMP-28) Expressed in Testis and Keratinocytes and in Response to Injury* , 2001, The Journal of Biological Chemistry.

[17]  A. Strongin,et al.  Processing of Integrin αv Subunit by Membrane Type 1 Matrix Metalloproteinase Stimulates Migration of Breast Carcinoma Cells on Vitronectin and Enhances Tyrosine Phosphorylation of Focal Adhesion Kinase* , 2002, The Journal of Biological Chemistry.

[18]  A. Gansmuller,et al.  Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. , 2005, Cancer research.

[19]  Carine Munaut,et al.  Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. , 2006, Cancer research.

[20]  P. Savagner.  Rise and Fall of Epithelial Phenotype , 2005 .

[21]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[22]  Hiroyuki Aburatani,et al.  Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.

[23]  M. Sporn,et al.  The tumour microenvironment as a target for chemoprevention , 2007, Nature Reviews Cancer.

[24]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[25]  C. López-Otín,et al.  Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. , 2004, The International journal of developmental biology.

[26]  I. Fidler,et al.  Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. , 2002, Journal of the National Cancer Institute.

[27]  K. Scott.  THE MAST CELL, ITS AMINES, AND TUMOR GROWTH IN RODENTS AND MAN , 1963, Annals of the New York Academy of Sciences.

[28]  P. Hornsby,et al.  Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. , 2007, Cancer research.

[29]  B. Fingleton,et al.  The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis , 1999, Current Biology.

[30]  Carine Munaut,et al.  MMP‐2 and MMP‐9 synergize in promoting choroidal neovascularization , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  R. Grenman,et al.  Matrix metalloproteinase‐19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation , 2003, International journal of cancer.

[32]  R. Williamson,et al.  Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. , 2003, Biochemical Society symposium.

[33]  S. Rafii,et al.  Preparing the "soil": the premetastatic niche. , 2006, Cancer research.

[34]  Christopher M. Overall,et al.  Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.

[35]  E. Petricoin,et al.  Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. , 2005, The Journal of clinical investigation.

[36]  S. Itohara,et al.  Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice , 2004, Oncogene.

[37]  M. Mareel,et al.  Clinical, cellular, and molecular aspects of cancer invasion. , 2003, Physiological reviews.

[38]  D. Albertson,et al.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.

[39]  G. Giannelli,et al.  Role of Cell Surface Metalloprotease Mt1-Mmp in Epithelial Cell Migration over Laminin-5 , 2000, The Journal of cell biology.

[40]  T. Tlsty,et al.  Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.

[41]  S. Grénman,et al.  Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. , 1999, The American journal of pathology.

[42]  P. Friedl,et al.  Tumour-cell invasion and migration: diversity and escape mechanisms , 2003, Nature Reviews Cancer.

[43]  Paula D. Bos,et al.  Mediators of vascular remodelling co-opted for sequential steps in lung metastasis , 2007, Nature.

[44]  A. Strongin,et al.  Matrix-dependent Proteolysis of Surface Transglutaminase by Membrane-type Metalloproteinase Regulates Cancer Cell Adhesion and Locomotion* , 2001, The Journal of Biological Chemistry.

[45]  K. Yano,et al.  Matrix metalloproteinase‐7 triggers the matricrine action of insulin‐like growth factor‐II via proteinase activity on insulin‐like growth factor binding protein 2 in the extracellular matrix , 2007, Cancer science.

[46]  P. Chambon,et al.  A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas , 1990, Nature.

[47]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[48]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[49]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[50]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[51]  S. Weiss,et al.  A cancer cell metalloprotease triad regulates the basement membrane transmigration program. , 2006, Genes & development.

[52]  A. Naukkarinen,et al.  Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions , 1997, International journal of cancer.

[53]  C. Giordano,et al.  Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. , 2007, Cancer research.

[54]  J. Foidart,et al.  Membrane associated proteases and their inhibitors in tumour angiogenesis , 2004, Journal of Clinical Pathology.

[55]  A. Harris,et al.  Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.

[56]  J. Foidart,et al.  Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient mice. , 2006, Cancer research.

[57]  S. Itohara,et al.  Contribution of host MMP‐2 and MMP‐9 to promote tumor vascularization and invasion of malignant keratinocytes , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  J. Foidart,et al.  Restricted expression of membrane type 1‐matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells , 2003, International journal of cancer.

[59]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[60]  C. Overall,et al.  Discovery of Chemokine Substrates for Matrix Metalloproteinases by Exosite Scanning: A New Tool for Degradomics , 2002, Biological chemistry.

[61]  J. Foidart,et al.  The Role of Stroma in Breast Carcinoma Growth In Vivo , 1998, Journal of Mammary Gland Biology and Neoplasia.

[62]  D. Hanahan,et al.  Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. , 1999, Genes & development.

[63]  Carlos López-Otín,et al.  Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.

[64]  W. Stetler-Stevenson,et al.  Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.

[65]  W. Roche.  The nature and significance of tumour‐associated mast cells , 1986, The Journal of pathology.

[66]  J. Foidart,et al.  In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell Malignancy , 1998, The Journal of cell biology.

[67]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[68]  M. Polette,et al.  Membrane-type metalloproteinases in tumor invasion. , 1998, The international journal of biochemistry & cell biology.

[69]  A. Strongin,et al.  Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. , 2002, The Journal of biological chemistry.

[70]  T. Skoog,et al.  MMP‐21 is expressed by macrophages and fibroblasts in vivo and in culture , 2006, Experimental dermatology.

[71]  Stephen J. Weiss,et al.  MT1-MMP–dependent neovessel formation within the confines of the three-dimensional extracellular matrix , 2004, The Journal of cell biology.

[72]  S. Groshen,et al.  Stromal Matrix Metalloproteinase-9 Regulates the Vascular Architecture in Neuroblastoma by Promoting Pericyte Recruitment , 2004, Cancer Research.

[73]  M. Shibuya,et al.  MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. , 2002, Cancer cell.

[74]  Hiroyuki Yamamoto,et al.  Role of Matrix Metalloproteinase-7 (Matrilysin) in Human Cancer Invasion, Apoptosis, Growth, and Angiogenesis , 2006, Experimental biology and medicine.

[75]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[76]  I. Stamenkovic,et al.  CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. , 2002, Genes & development.

[77]  H. Mori,et al.  Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration , 2001, The Journal of cell biology.

[78]  J. Klein,et al.  What are subcutaneous adipocytes really good for…? , 2007, Experimental dermatology.

[79]  F. Balkwill,et al.  Chemokine stimulation of monocyte matrix metalloproteinase‐9 requires endogenous TNF‐α  , 2002, European journal of immunology.

[80]  R. Kalluri,et al.  Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth. , 2005, Biochemical and biophysical research communications.

[81]  P. Zigrino,et al.  Tumor-stroma interactions: their role in the control of tumor cell invasion. , 2005, Biochimie.

[82]  Andrew J. Ewald,et al.  Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.

[83]  C. Gilles,et al.  Matrix Metalloproteases and Epithelial-to-Mesenchymal Transition , 2005 .

[84]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[85]  M. Kuwano,et al.  Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL‐1α , 2000 .

[86]  Carine Munaut,et al.  Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. , 2002, Diabetes.

[87]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[88]  M. Mareel,et al.  Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. , 2001, Journal of cell science.

[89]  A. Noël,et al.  Membrane type-matrix metalloproteinases and tumor progression. , 2005, Biochimie.

[90]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[91]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[92]  P. E. Van den Steen,et al.  Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. , 2000, Blood.

[93]  C. López-Otín,et al.  Membrane type-matrix metalloproteinases (MT-MMP). , 2003, Current topics in developmental biology.

[94]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[95]  I. Stamenkovic,et al.  Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.

[96]  K. Suzuki,et al.  Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. , 1989, The Journal of clinical investigation.

[97]  E. Rosenthal,et al.  Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo , 2006, BMC Cancer.

[98]  J. Laissue,et al.  MMP‐19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours , 2001, The Journal of pathology.

[99]  G. Davis,et al.  Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. , 2006, The journal of investigative dermatology. Symposium proceedings.

[100]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[101]  J. Foidart,et al.  Inhibition of stromal matrix metalloproteases: Effects on breast‐tumor promotion by fibroblasts , 1998, International journal of cancer.

[102]  A. Mantovani,et al.  The origin and function of tumor-associated macrophages. , 1992, Immunology today.

[103]  R. W. Rauser,et al.  Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[104]  A. Noël,et al.  Diet-Induced Obesity and Reduced Skin Cancer Susceptibility in Matrix Metalloproteinase 19-Deficient Mice , 2004, Molecular and Cellular Biology.

[105]  P. Nelson,et al.  The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. , 2006, Cancer research.

[106]  C. Sautès-Fridman,et al.  High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. , 2001, Cancer research.

[107]  Peter Carmeliet,et al.  Angiogenesis in life, disease and medicine , 2005, Nature.

[108]  Pieter Koolwijk,et al.  Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3-MMP. , 2004, The Journal of clinical endocrinology and metabolism.

[109]  R. Ala-aho,et al.  Collagenases in cancer. , 2005, Biochimie.

[110]  M. Barbacid,et al.  Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3* , 1997, The Journal of Biological Chemistry.

[111]  P. Wolters,et al.  Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. , 1999, Journal of immunology.

[112]  Agnes W. O'Brien.  Seed and Soil , 1905, The Elementary School Teacher.

[113]  W. Stetler-Stevenson,et al.  Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. , 1996, Cell.

[114]  R. Pierce,et al.  Matrix metalloproteinases generate angiostatin: effects on neovascularization. , 1998, Journal of immunology.

[115]  L. A. Richards,et al.  Increased mast cell density in invasive melanoma , 1998, Journal of cutaneous pathology.

[116]  J. Keski‐Oja,et al.  Epilysin (MMP-28) induces TGF-β mediated epithelial to mesenchymal transition in lung carcinoma cells , 2006, Journal of Cell Science.

[117]  B. Fingleton,et al.  Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells. , 2005, Experimental cell research.

[118]  K. Brew,et al.  Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.